A Look At The Intrinsic Value Of BioLife Solutions, Inc. (NASDAQ:BLFS)
The analyst price target for BLFS is slightly higher than the fair value estimate. Using a discounted cash flow model, the company's value is calculated to be US$1.1b, indicating the stock is trading at an 11% discount.